Yanwen Jiang
Amgen (United States)(US)GenentechPeking University(CN)Acentech (United States)(US)Peking University International Hospital(CN)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Protein Degradation and Inhibitors, Cancer-related gene regulation, Acute Lymphoblastic Leukemia research
Most-Cited Works
- → EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation(2013)832 cited
- → The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development(2015)440 cited
- → Fixed Duration of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease and Prolongs Survival: Post-Treatment Follow-Up of the MURANO Phase III Study(2018)295 cited
- → CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas(2016)265 cited
- → Mutational Cooperativity Linked to Combinatorial Epigenetic Gain of Function in Acute Myeloid Leukemia(2015)245 cited
- → The Leukemogenicity of AML1-ETO Is Dependent on Site-Specific Lysine Acetylation(2011)236 cited